Musculoskeletal Chronic Graft versus Host Disease-A Rare Complication to Allogeneic Hematopoietic Stem Cell Transplant: A Case-Based Report and Review of the Literature

被引:3
|
作者
Kvinge, Alexander Datland [1 ]
Kvammen, Tobias [1 ]
Miletic, Hrvoje [2 ,3 ]
Bindoff, Laurence Albert [4 ,5 ]
Reikvam, Hakon [1 ,6 ]
机构
[1] Univ Bergen, Inst Clin Sci, Fac Med, N-5021 Bergen, Norway
[2] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway
[3] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway
[4] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway
[5] Univ Bergen, Inst Med Sci, Fac Med, N-5021 Bergen, Norway
[6] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway
关键词
allogenic hematopoietic stem cell transplantation; graft-versus-host disease; musculoskeletal pathology; fasciitis; myositis; creatine kinase; immunosuppressive treatment; CONSENSUS DEVELOPMENT PROJECT; CLINICAL-TRIALS; CHRONIC GVHD; POLYMYOSITIS; MANIFESTATION; MYOSITIS; DIAGNOSIS; PATHOLOGY; CRITERIA;
D O I
10.3390/curroncol29110663
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Musculoskeletal graft versus host disease (GVHD) is a rare manifestation of chronic GVHD (cGVHD) following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Left untreated, the disease can cause extensive damage to muscle tissue and joints. We describe a 62-year-old male with musculoskeletal GVHD and generalized muscle pain and stiffness. In addition, we performed a systemic literature review based on published cases of musculoskeletal GVHD between 1983 and 2019. We identified 85 cases, 62% male and 38% female with an age of 4-69 years and median age of 39 years at diagnosis. The majority of patients (72%) also had manifestations of cGVHD in at least one other organ system, most frequently the skin (52%), followed by oropharyngeal mucosa (37%), and pulmonary and gastrointestinal tract (GI tract) (21%). We conclude that, while musculoskeletal cGVHD is a rare complication of allo-HSCT, it remains a serious and debilitating risk that must be considered in patients with muscle pain, muscle weakness, joint stiffness, and tissue inflammation. Early intervention is critical for the patient's prognosis.
引用
收藏
页码:8415 / 8430
页数:16
相关论文
共 50 条
  • [21] The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience
    Sarici, Ahmet
    Erkurt, Mehmet Ali
    Kuku, Irfan
    Kaya, Emin
    Berber, Ilhami
    Bicim, Soykan
    Hidayet, Emine
    Kaya, Ahmet
    Bahcecioglu, Omer Faruk
    Tanriverdi, Lokman Hekim
    Ozkan, Sidika Gulkan
    ISTANBUL MEDICAL JOURNAL, 2023, 24 (02): : 216 - 220
  • [22] Gastrointestinal Biopsies for Evaluation of Acute Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Patients
    Azad, Shweta
    Malhotra, Veena
    Kirtani, Pawan
    Choudhary, Dharma
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2019, 35 (01) : 83 - 88
  • [23] Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Omer, Aazim K.
    Weisdorf, Daniel J.
    Lazaryan, Aleksandr
    Shanley, Ryan
    Blazar, Bruce R.
    MacMillan, Margaret L.
    Brunstein, Claudio
    Bejanyan, Nelli
    Arora, Mukta
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (05) : 879 - 883
  • [24] Salivary Proteomic Analysis and Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Chiusolo, Patrizia
    Giammarco, Sabrina
    Fanali, Chiara
    Bellesi, Silvia
    Metafuni, Elisabetta
    Sica, Simona
    Iavarone, Federica
    Cabras, Tiziana
    Messana, Irene
    Leone, Giuseppe
    Castagnola, Massimo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (06) : 888 - 892
  • [25] Genital graft versus host disease in women after allogeneic hematopoietic stem cell transplantation - a single center experience
    Goldsher, Yulia Wilk
    Sacher, Bina Cohen
    Cohen, May
    Yeshurun, Moshe
    Sabah, Gad
    Eitan, Ram
    Krissi, Haim
    ANNALS OF HEMATOLOGY, 2025, 104 (01) : 773 - 779
  • [26] The role of serum uric acid in the prediction of graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
    Ghasemi, Katayoon
    Parkhideh, Sayeh
    Kazemi, Mohammad Hossein
    Salimi, Maryam
    Salari, Sina
    Nalini, Ronak
    Hajifathali, Abbas
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2020, 34 (07)
  • [27] B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Juric, Mateja Kralj
    Shevtsov, Maxim
    Mozes, Petra
    Ogonek, Justyna
    Crossland, Rachel E.
    Dickinson, Anne M.
    Greinix, Hildegard T.
    Holler, Ernst
    Weissinger, Eva M.
    Multhoff, Gabriele
    FRONTIERS IN IMMUNOLOGY, 2017, 7
  • [28] Case report: Nephrotic syndrome and portal hypertensive ascites after allogeneic hematopoietic stem cell transplantation: a rare manifestation of chronic graft-versus-host disease
    Ai, SanXi
    Wen, YuBing
    Fan, XiaoHong
    Hua, TianRui
    Ye, Wei
    Li, XueMei
    Qin, Yan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [29] Prevalence of oral chronic graft versus host disease after allogeneic stem cell transplantation
    Yamada, Ayaka
    Torihata, Sayaka
    Shimoide, Takeshi
    Lee, Atsushi-Doksa
    Kinoshita, Yuko
    Kawaguchi, Miku
    Ashida, Takashi
    Matsumura, Itaru
    Enomoto, Akifumi
    ORAL SCIENCE INTERNATIONAL, 2024, 21 (02) : 249 - 254
  • [30] Voriconazole-Induced Phototoxicity Masquerading as Chronic Graft-versus-Host Disease of the Skin in Allogeneic Hematopoietic Cell Transplant Recipients
    Patel, Asha R.
    Turner, Maria L.
    Baird, Kristin
    Gea-Banacloche, Juan
    Mitchell, Sandra
    Pavletic, Steven Z.
    Wise, Barbara
    Cowen, Edward W.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (03) : 370 - 376